Recently transmural healing (TH) has become a subject of increasing interest as a potential therapeutic purpose for inflammatory bowel disease (IBD). Crohn’s disease (CD) is characterized by chronic inflammation of the gastrointestinal tract, which can involve any part of the digestive tract, and the lesions are usually discontinuous, with progressive and destructive transmural lesions that can lead to irreversible damage such as fibrotic strictures, complications such as fistulas and abscesses. Disease remission remains the primary goal of therapeutic management; however transmural healing is a very promising endpoint for monitoring treatment response. Along with small bowel imaging tests such as computed tomography scans Intestinal imaging (CTE), magnetic resonance intestinal imaging (MRE), intestinal ultrasound (IUS) and other related imaging technologies are popularized in CD diagnosis and treatment benefit. Transmural healing has been initially used in clinical practice and the correlation between its rules and long-term clinical remission has been explored.
References
[1]
Zhang, M. and Jiang, C.H. (2020) Progress in the Application of Transmural Healing as an Indicator to Evaluate the Remission of Crohn’s Disease. Chinese General Practice, No. 30, 3884-3887.
[2]
Gajendran, M., Loganathan, P., Catinella, A.P., et al. (2018) A Comprehensive Review and Update on Crohn’s Disease. Disease-a-Month, 64, 20-57. https://doi.org/10.1016/j.disamonth.2017.07.001
[3]
Fraquelli, M., Castiglione, F., Calabrese, E., et al. (2020) Impact of Intestinal Ultrasound on the Management of Patients with Inflammatory Bowel Disease: How to Apply Scientific Evidence to Clinical Practice. Digestive and Liver Disease, 52, 9-18. https://doi.org/10.1016/j.dld.2019.10.004
[4]
Pariente, B., Cosnes, J., Danese, S., et al. (2011) Development of the Crohn’s Disease Digestive Damage Score, the Lémann Score. Inflammatory Bowel Diseases, 17, 1415-1422. https://doi.org/10.1002/ibd.21506
[5]
Lafeuille, P., Hordonneau, C., Vignette, J., et al. (2021) Transmural Healing and Mri Healing Are Associated with Lower Risk of Bowel Damage Progression than Endoscopic Mucosal Healing in Crohn’s Disease. Alimentary Pharmacology and Therapeutics, 53, 577-586. https://doi.org/10.1111/apt.16232
[6]
Deepak, P., Fletcher, J.G., Fidler, J.L., et al. (2016) Radiological Response Is Associated with Better Long-Term Outcomes and Is a Potential Treatment Target in Patients with Small Bowel Crohn’s Disease. American Journal of Gastroenterology, 111, 997-1006. https://doi.org/10.1038/ajg.2016.177
[7]
Eder, P., Katulska, K., Krela-Kaźmierczak, I., et al. (2015) The Influence of Anti-TNF Therapy on the Magnetic Resonance Enterographic Parameters of Crohn’s Disease Activity. Abdominal Imaging, 40, 2210-2218. https://doi.org/10.1007/s00261-015-0466-0
[8]
Baumgart, D.C. and Sandborn, W.J. (2012) Crohn’s Disease. The Lancet, 380, 1590-1605. https://doi.org/10.1016/S0140-6736(12)60026-9
[9]
Moussata, D., Goetz, M., Gloeckner, A., et al. (2011) Confocal Laser Endomicroscopy Is a New Imaging Modality for Recognition of Intramucosal Bacteria in Inflammatory Bowel Disease in Vivo. Gut, 60, 26-33. https://doi.org/10.1136/gut.2010.213264
[10]
Frank, D.N., Amand, A.L.S., Feldman, R.A., et al. (2007) Molecular-Phylogenetic Characterization of Microbial Community Imbalances in Human Inflammatory Bowel Diseases. Proceedings of the National Academy of Sciences of the United States of America, 104, 13780-13785. https://doi.org/10.1073/pnas.0706625104
[11]
Willing, B.P., Dicksved, J., Halfvarson, J., et al. (2010) A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary with Inflammatory Bowel Disease Phenotypes. Gastroenterology, 139, 1844-1854.E1. https://doi.org/10.1053/j.gastro.2010.08.049
[12]
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O.G.L., Gratadoux, J., Blugeon, S., Bridonneau, C., Furet, J., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottière, H.M., Doré, J., Marteau, P., Seksik, P., Langella, P., et al. (2008) Faecalibacterium Prausnitzii Is an Anti-Inflammatory Commensal Bacterium Identified by Gut Microbiota Analysis of Crohn Disease Patients. Proceedings of the National Academy of Sciences of the United States of America, 105, 16731-16736. https://doi.org/10.1073/pnas.0804812105
[13]
Amatullah, H., Fraschilla, I., Digumarthi, S., et al. (2022) Epigenetic Reader Sp140 Loss of Function Drives Crohn’s Disease Due to Uncontrolled Macrophage Topoisomerases. Cell, 185, 3232-3247.E18. https://doi.org/10.1016/j.cell.2022.06.048
[14]
Gao, J., Zhao, X., Hu, S., et al. (2022) Gut Microbial Dl-Endopeptidase Alleviates Crohn’s Disease via the Nod2 Pathway. Cell Host and Microbe, 30, 1435-1449.E9. https://doi.org/10.1016/j.chom.2022.08.002
[15]
Matsuzawa-Ishimoto, Y., Yao, X., Koide, A., et al. (2022) The γδ Iel Effector Api5 Masks Genetic Susceptibility to Paneth Cell Death. Nature, 610, 547-554. https://doi.org/10.1038/s41586-022-05259-y
[16]
Ou, Y.X. and Chen, W.X. (2012) The Role of Epithelial Mesenchymal Transition in Intestinal Fibrosis of Crohn’s Disease. International Journal of Digestive Diseases, 32, 18-20.
[17]
Kalluri, R. (2009) Emt: When Epithelial Cells Decide to Become Mesenchymal-Like Cells. Journal of Clinical Investigation, 119, 1417-1419. https://doi.org/10.1172/JCI39675
[18]
Chen, N. and Liu, Y.L. (2010) The Mechanism and Clinical Treatment of Intestinal Fibrosis in Crohn’s Disease . World Chinese Journal of Digestology, 18, 2017-2019. https://doi.org/10.11569/wcjd.v18.i19.2017
[19]
Weinstein-Nakar, I., Focht, G., Church, P., et al. (2018) Associations among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children with Crohn’s Disease. Clinical Gastroenterology and Hepatology. The American Gastroenterological Association, 16, 1089-1097.E4. https://doi.org/10.1016/j.cgh.2018.01.024
[20]
Castiglione, F., Testa, A., Rea, M., et al. (2013) Transmural Healing Evaluated by Bowel Sonography in Patients with Crohn’s Disease on Maintenance Treatment with Biologics. Inflammatory Bowel Diseases, 19, 1928-1934. https://doi.org/10.1097/MIB.0b013e31829053ce
[21]
Ta, A.D., Ollberding, N.J., Karns, R., et al. (2021) Association of Baseline Luminal Narrowing with Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease. Inflammatory Bowel Diseases, 27, 1707-1718. https://doi.org/10.1093/ibd/izaa339
[22]
Castiglione, F., Imperatore, N., Testa, A., et al. (2022) Exploring the Concept of Deep Remission in Crohn’s Disease: Correlation between Transmural Healing and Biomarkers. Therapeutic Advances in Gastroenterology, 15, 1-13. https://doi.org/10.1177/17562848221110643
[23]
Hommes, D., Colombel, J.F., Emery, P., et al. (2012) Changing Crohn’s Disease Management: Need for New Goals and Indices to Prevent Disability and Improve Quality of Life. Journal of Crohn’s and Colitis, 6, S224-S234. https://doi.org/10.1016/S1873-9946(12)60502-9
[24]
Cheng, W.J., Qin, S., Liang, C.H., et al. (2016) Ultrasound Evaluation Method and Value of Transmural Healing in Crohn’s Disease Ase. Chinese Journal of Inflammatory Bowel Diseases, 1-23.
[25]
Al-Ani, A.H., Vaughan, R., Christensen, B., et al. (2022) Treat to Transmural Healing: How to Incorporate Intestinal Ultrasound into the Treatment of Inflammatory Bowel Disease. British Journal of Radiology, 95, Article ID: 20211174. https://doi.org/10.1259/bjr.20211174
[26]
Ultrasonography, T. and Contrast, S.I. (2005) Crohn’s Disease : A Comparative Prospective Study of Transabdominal Ultrasonography, Small Intestine Contrast Ultrasonography, and Small Bowel Enema. Inflammatory Bowel Diseases, 11, 139-145. https://doi.org/10.1097/00054725-200502000-00007
[27]
Parente, F., Greco, S., Molteni, M., et al. (2003) Role of Early Ultrasound in Detecting Inflammatory Intestinal Disorders and Identifying Their Anatomical Location within the Bowel. Alimentary Pharmacology and Therapeutics, 18, 1009-1016. https://doi.org/10.1046/j.1365-2036.2003.01796.x
[28]
Nylund, K., Maconi, G., Hollerweger, A., et al. (2017) Recommendations and Guidelines for Gastrointestinal Ultrasound—Part 1: Examination Techniques and Normal Findings (Short Version). Ultraschall in der Medizin, 38, 273-284. https://doi.org/10.1055/s-0042-115410
[29]
Castiglione, F., Mainenti, P., Testa, A., et al. (2017) Cross-Sectional Evaluation of Transmural Healing in Patients with Crohn’s Disease on Maintenance Treatment with Anti-TNF α Agents. Digestive and Liver Disease, 49, 484-489. https://doi.org/10.1016/j.dld.2017.02.014
[30]
Ripollés, T., Paredes, J.M., Martínez-Pérez, M.J., et al. (2016) Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-Year Sonographic Response and Clinical Outcome in Crohn’s Disease: A Multicenter Study. Inflammatory Bowel Diseases, 22, 2465-2473. https://doi.org/10.1097/MIB.0000000000000882
[31]
Kucharzik, T., Wilkens, R., Maconi, G., et al. (2020) Intestinal Ultrasound Response and Transmural Healing after Ustekinumab Induction in Crohn’s Disease: Week 16 Interim Analysis of the Stardust Trial Substudy.Zeitschrift für Gastroenterologie,58, e77. https://doi.org/10.1055/s-0040-1712250
[32]
Civitelli, F., Nuti, F., Oliva, S., et al. (2016) Looking beyond Mucosal Healing: Effect of Biologic Therapy on Transmural Healing in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases, 22, 2418-2424. https://doi.org/10.1097/MIB.0000000000000897
[33]
Helwig, U., Fischer, I., Hammer, L., et al. (2022) Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets? Journal of Crohn’s and Colitis, 16, 57-67. https://doi.org/10.1093/ecco-jcc/jjab106
[34]
Furfaro, F., Buono, A.D., Allocca, M., et al. (2021) Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale? Life, 11, Article 649. https://doi.org/10.3390/life11070649
[35]
Siddiki, H.A., Fidler, J.L., Fletcher, J.G., et al. (2009) Prospective Comparison of State-Of-The-Art Mr Enterography and Ct Enterography in Small-Bowel Crohn’s Disease. American Journal of Roentgenology, 193, 113-121. https://doi.org/10.2214/AJR.08.2027
[36]
Laterza, L., Piscaglia, A.C., Minordi, L.M., et al. (2018) Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease. Digestive Diseases, 36, 184-193. https://doi.org/10.1159/000487589
[37]
Fujimura, H., Hashimoto, S., Shimizu, K., et al. (2022) The Evaluation of Transmural Healing by Low-Dose Computed Tomography Enterography in Patients with Crohn’s Disease. Internal Medicine, 61, 2999-3007. https://doi.org/10.2169/internalmedicine.9066-21
[38]
Taylor, S.A., Mallett, S., Bhatnagar, G., et al. (2018) Diagnostic Accuracy of Magnetic Resonance Enterography and Small Bowel Ultrasound for the Extent and Activity of Newly Diagnosed and Relapsed Crohn’s Disease (Metric): A Multicentre Trial. The Lancet Gastroenterology and Hepatology, 3, 548-558. https://doi.org/10.1016/S2468-1253(18)30161-4
[39]
Liu, D.C., Guo, T.D., Wu, G.X., et al. (2022) The Value of MR and CT Enterography in the Diagnosis and Efficacy Evaluation of Crohn’s Disease. Chinese Journal of CT and MRI, No. 1, 141-143.
[40]
Gourtsoyiannis, N.C., Papanikolaou, N. and Karantanas, A. (2006) Magnetic Resonance Imaging Evaluation of Small Intestinal Crohn’s Disease. Best Practice & Research Clinical Gastroenterology, 20, 137-156. https://doi.org/10.1016/j.bpg.2005.09.002
[41]
HallÉ, E., Azahaf, M., Duveau, N., et al. (2020) Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn’s Disease. Digestive Diseases and Sciences, 65, 2664-2674. https://doi.org/10.1007/s10620-019-05979-8
[42]
Vaughan, R., Tjandra, D., Patwardhan, A., et al. (2022) Toward Transmural Healing : Sonographic Healing Is Associated with Improved Long-Term Outcomes in Patients with Crohn’s Disease. Alimentary Pharmacology & Therapeutics, 56, 84-94. https://doi.org/10.1111/apt.16892
[43]
Buisson, A., Hordonneau, C., Goutorbe, F., et al. (2019) Bowel Wall Healing Assessed Using Magnetic Resonance Imaging Predicts Sustained Clinical Remission and Decreased Risk of Surgery in Crohn’s Disease. Journal of Gastroenterology, 54, 312-320. https://doi.org/10.1007/s00535-018-1505-8
[44]
Choi, S.Y., Kwon, Y., Choi, S., et al. (2023) Infliximab Trough Levels Are Associated with Endoscopic Healing But Not with Transmural Healing at One Year Treatment with Infliximab in Pediatric Patients with Crohn’s Disease. Frontiers in Immunology, 14, Article 1192827. https://doi.org/10.3389/fimmu.2023.1192827
[45]
Zhou, L., Hu, C., Zhang, R., et al. (2023) Early Transmural Healing and Its Predictors Assessed by Magnetic Resonance Enterography in Patients with Crohn’s Disease Receiving Ustekinumab. Therapeutic Advances in Gastroenterology, 16. https://doi.org/10.1177/17562848231170947
[46]
Ma, L., Li, W., Zhuang, N., et al. (2021) Comparison of Transmural Healing and Mucosal Healing as Predictors of Positive Long-Term Outcomes in Crohn’s Disease. Therapeutic Advances in Gastroenterology, 14. https://doi.org/10.1177/17562848211016259
[47]
Geyl, S., Guillo, L., Laurent, V., et al. (2021) Transmural Healing: the Ultimate Therapeutic Goal in Crohn’s Disease? The Lancet Gastroenterology and Hepatology, 6, 659-667. https://doi.org/10.1016/S2468-1253(21)00096-0
[48]
Castiglione, F., Imperatore, N., Testa, A., et al. (2019) One-Year Clinical Outcomes with Biologics in Crohn’s Disease: Transmural Healing Compared with Mucosal or No Healing. Alimentary Pharmacology and Therapeutics, 49, 1026-1039. https://doi.org/10.1111/apt.15190
[49]
Fernandes, S.R., Serrazina, J., Botto, I.A., et al. (2023) Transmural Remission Improves Clinical Outcomes Up to 5 Years in Crohn’s Disease. United European Gastroenterology Journal, 11, 51-59. https://doi.org/10.1002/ueg2.12356
[50]
Sauer, C.G., Middleton, J.P., Mccracken, C., et al. (2016) Magnetic Resonance Enterography Healing and Magnetic Resonance Enterography Remission Predicts Improved Outcome in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition, 62, 378-383. https://doi.org/10.1097/MPG.0000000000000976
[51]
Messadeg, L., Hordonneau, C., Bouguen, G., et al. (2020) Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy. Journal of Crohn’s and Colitis, 14, 1524-1534. https://doi.org/10.1093/ecco-jcc/jjaa098
[52]
Sauer, C.G., Kugathasan, S., Martin, D.R., et al. (2011) Medical Radiation Exposure in Children with Inflammatory Bowel Disease Estimates High Cumulative Doses. Inflammatory Bowel Diseases, 17, 2326-2332. https://doi.org/10.1002/ibd.21626
[53]
Eder, P., Łykowska-Szuber, L., Katulska, K., et al. (2016) Intestinal Healing after Anti-TNF Induction Therapy Predicts Long-Term Response to One-Year Treatment in Patients with Ileocolonic Crohn’s Disease Naive to Anti-TNF Agents. Przeglad Gastroenterologiczny, 11, 187-193. https://doi.org/10.5114/pg.2015.55185
[54]
Ripollés, T., Paredes, J.M., Martínez-Pérez, M.J., et al. (2016) Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-Year Sonographic Response and Clinical Outcome in Crohn’s Disease : A Multicenter Study. Inflammatory Bowel Diseases, 22, 2465-2473. https://doi.org/10.1097/MIB.0000000000000882
[55]
Paredes, J.M., Moreno, N., Latorre, P., et al. (2019) Clinical Impact of Sonographic Transmural Healing after Anti-TNF Antibody Treatment in Patients with Crohn’s Disease. Digestive Diseases and Sciences, 64, 2600-2606. https://doi.org/10.1007/s10620-019-05567-w
[56]
Huang, Z. and Cheng, W. (2022) Transmural Healing Evaluated by Intestinal Ultrasound in Patients with Crohn’s Disease Treated with Infliximab. Journal of Biosciences and Medicines, 10, 12-21. https://doi.org/10.4236/jbm.2022.1012002
[57]
Albshesh, A., Ungar, B., Horin, S.Ben., et al. (2020) Terminal Ileum Thickness during Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease. Inflammatory Bowel Diseases, 26, 1619-1625. https://doi.org/10.1093/ibd/izaa219
[58]
Rev, J., Ordás, I., Buisson, A., et al. (2023) Early Biological Therapy within the First 12 Months after Diagnosis Leads to Higher Clinical, Endoscopic, and Transmural Remission in Crohn’s Disease: European Multicentre Study with a Propensityscore Matched Analysis. Journal of Crohn’s and Colitis, 171, 711-713.
[59]
Chen, J.M., He, L.W., Yan, T., et al. (2019) Oral Exclusive Enteral Nutrition Induces Mucosal and Transmural Healing in Patients with Crohn’s Disease. Gastroenterology Report, 7, 176-184. https://doi.org/10.1093/gastro/goy050
[60]
Dolinger, M.T. and Dubinsky, M.C. (2022) The Pediatric Inflammatory Crohn’s Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn’s Disease Monitoring and Healing. Gastroenterology, 163, 1166-1167. https://doi.org/10.1053/j.gastro.2022.08.047
[61]
Shen, H., Zhu, L. and Zhang, L. (2022) Exploring the Integrated Treatment Strategy of Traditional Chinese and Western Medicine for Crohn’s Disease under the Background of Biological Agents. Journal of Nanjing University of Traditional Chinese Medicine, 38, 739-742.
